创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the characteristics of in vitro testing platforms

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-14 13:27
  • Views:

(Summary description)With the continuous development of science and technology, the medical field is also gradually undergoing deep changes. InnoModels' in vitro test platform, with its advantages of rapidity, accuracy, sensitivity and ease of operation, not only promotes the development of the medical field, but also plays an important role in many fields such as environmental protection and food safety

InnoModels Biotechnology: What are the characteristics of in vitro testing platforms

(Summary description)With the continuous development of science and technology, the medical field is also gradually undergoing deep changes. InnoModels' in vitro test platform, with its advantages of rapidity, accuracy, sensitivity and ease of operation, not only promotes the development of the medical field, but also plays an important role in many fields such as environmental protection and food safety

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-14 13:27
  • Views:
Information

With the continuous development of science and technology, the medical field is also gradually undergoing deep changes. InnoModels' in vitro test platform, with its advantages of rapidity, accuracy, sensitivity and ease of operation, not only promotes the development of the medical field, but also plays an important role in many fields such as environmental protection and food safety.
First of all, the InnoModels Biotechnology in vitro test platform has extremely high sensitivity. This sensitivity allows it to detect microorganisms in trace amounts, and even the presence of trace amounts will not be missed. This advantage makes the platform valuable for early disease diagnosis, infection surveillance and other applications. While traditional testing methods often struggle to detect the presence of trace microorganisms due to insufficient sensitivity, the in vitro testing platform of InnoModels Biotechnology is able to accurately capture these microorganisms, helping doctors to detect diseases earlier and improve the effectiveness of treatment.
Second, the platform's cellular technology is more accurate than traditional detection methods. While traditional testing methods may result in false positives or misjudgments due to a variety of factors, InnoModels' in vitro testing platform is able to accurately identify target microorganisms, avoiding false positives or misjudgments. This accuracy allows doctors to trust the results of the platform, providing a more reliable basis for disease treatment and monitoring.

 


In addition, InnoModels' in vitro testing platform is easy to operate and requires no special skills or equipment. This lowers the threshold for using the platform, enabling more medical institutions and individuals to use this highly efficient testing method. At the same time, this ease of operation also greatly improves testing efficiency, enabling people to complete a large number of testing tasks in a short period of time.
In addition, InnoModels' in vitro testing platform has a wide range of applications. It can be used not only for disease treatment and monitoring in the medical field, but also in many other fields such as environmental protection and food safety. In environmental protection, the platform can be used to detect microbial contamination in water and soil, providing a scientific basis for environmental protection. In terms of food safety, the platform can be used to detect microbial contamination in food to ensure the safety of people's diet.
Overall, the in vitro testing platform of InnoModels Biotechnology is gradually changing our medical, environmental protection and food safety fields with its advantages of rapidity, accuracy, sensitivity and ease of operation. It not only improves the efficiency of disease diagnosis and treatment, but also provides strong scientific and technological support for environmental protection and food safety. In the future, we have reason to believe that the in vitro testing platform of InnoModels will play an even more important role in promoting the development of medical science and technology and related fields, and make greater contributions to the health and well-being of human beings.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司